Clinical Trial Update: A Study Conducted Over 3 Periods to Look at the Drug in the Body [Phase 1]

View source ↗

Summary

This update describes a Phase 1 pharmacokinetics study conducted over three periods to assess how the drug is processed in the body in individuals with Type 2 D…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED